LYPE:XETRA:XETRA-Lyxor MSCI World Health Care TR UCITS ETF - C-EUR EUR (EUR)

ETF | Others |

Last Closing

USD 430.4

Change

+3.15 (+0.74)%

Market Cap

N/A

Volume

55.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

ETFs Containing LYPE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.93% 15% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.93% 21% F 21% F
Trailing 12 Months  
Capital Gain -9.16% 10% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.16% 15% F 20% F
Trailing 5 Years  
Capital Gain 39.40% 46% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.40% 47% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 9.67% 66% D+ 66% D+
Dividend Return 9.67% 65% D 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.94% 62% D 70% C-
Risk Adjusted Return 97.21% 85% B 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike